acoramidis hydrochloride
acoramidis hydrochloride is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Attruby. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- acoramidis hydrochloride
- Brand Names
- Attruby
- Application Number
- NDA216540
- Sponsor
- BridgeBio Pharma, Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ACORAMIDIS HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE ATTRUBY is indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization. ATTRUBY is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization. ( 1 , 2.1 )